|
PRKRIR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.38159999499388E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.33999999774437E-08 |
| Normal-vs-Stage2 |
4.284000E-03 |
| Normal-vs-Stage3 |
3.98280000091233E-08 |
| Normal-vs-Stage4 |
4.790700E-04 |
| Stage1-vs-Stage2 |
7.670600E-01 |
| Stage1-vs-Stage3 |
2.352600E-01 |
| Stage1-vs-Stage4 |
8.518400E-01 |
| Stage2-vs-Stage3 |
3.758600E-01 |
| Stage2-vs-Stage4 |
7.217800E-01 |
| Stage3-vs-Stage4 |
6.311600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.0071000000611E-07 |
| Normal-vs-AfricanAmerican |
3.23440000338238E-08 |
| Normal-vs-Asian |
3.823000E-03 |
| Caucasian-vs-AfricanAmerican |
5.656000E-02 |
| Caucasian-vs-Asian |
4.207000E-01 |
| AfricanAmerican-vs-Asian |
8.043200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.03740000320951E-08 |
| Normal-vs-Female |
4.82220000042055E-07 |
| Male-vs-Female |
6.626000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.62059999999831E-05 |
| Normal-vs-Age(41-60Yrs) |
6.93319999967024E-07 |
| Normal-vs-Age(61-80Yrs) |
3.56090000042109E-07 |
| Normal-vs-Age(81-100Yrs) |
2.375900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.361200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.078000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.193200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.003000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.601200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.466200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.168400E-02 |
| Normal-vs-Grade 2 |
1.89114999999962E-05 |
| Normal-vs-Grade 3 |
4.02411437505634E-12 |
| Normal-vs-Grade 4 |
1.555540E-03 |
| Grade 1-vs-Grade 2 |
8.641000E-01 |
| Grade 1-vs-Grade 3 |
3.454000E-01 |
| Grade 1-vs-Grade 4 |
9.170800E-01 |
| Grade 2-vs-Grade 3 |
3.681900E-03 |
| Grade 2-vs-Grade 4 |
6.154800E-01 |
| Grade 3-vs-Grade 4 |
3.500400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.58240000015209E-07 |
| Normal-vs-ccB subtype |
1.56928999999195E-05 |
| ccA subtype-vs-ccB subtype |
9.878600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.54271999999178E-05 |
| Normal-vs-N1 |
4.152800E-04 |
| N0-vs-N1 |
3.151800E-01 |
|
|
